Covıd-19, Coronavirus, Vaccine, Taiwan

Covıd-19, Coronavirus

Taiwan says no progress in Pfizer-BioNTech COVID-19 vaccine talks

Taiwan says no progress in Pfizer-BioNTech COVID-19 vaccine talks

29/3/2021 10:29:00 AM

Taiwan says no progress in Pfizer-BioNTech COVID-19 vaccine talks

TAIPEI: There has been no progress on talks to seal a deal with Germany's BioNTech for its COVID-19 vaccine though talks are continuing, Taiwan ese ...

Speaking at parliament, Chen was downbeat on the chances for finalising the agreement."At present there has been no further progress, and the opportunity for both to complete the contract is getting less and less," he added.Taiwan has a contract for 5 million of Moderna's COVID-19 shot, a messenger RNA (mRNA) vaccine that relies on similar technology as that used by the Pfizer-BioNTech one.

Victoria JC student infected with Covid-19; 103 people quarantined, 2,200 others to be swabbed 7 community cases among 20 new COVID-19 infections in Singapore Victoria Junior College student positive for COVID-19; more than 100 students, staff members quarantined

AdvertisementAdvertisementChen said that with the Moderna ones coming, as well as domestically made vaccines in development, there was less urgency to obtain the Pfizer-BioNTech one, though Taiwan would still like them if possible."We are still in communication with them," he added.

BioNTech did not immediately respond to a request for comment.BioNTech signed a deal with Chinese firm Shanghai Fosun Pharmaceutical Group to exclusively develop and commercialise COVID-19 vaccine products developed using its mRNA technology in mainland China, Hong Kong, Macau and Taiwan. In return Fosun agreed to pay up to US$85 million in licensing fees and invest US$50 million for a stake in the German firm.

AdvertisementBioNTech's development and distribution partner for the rest of the world is US firm Pfizer. Read more: CNA »

S'pore-HK air travel bubble starts May 26, 2 daily flights capped at 200 passengers each for first 2 weeks